Toast, Inc. (NYSE:TOST) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 19, 2025 Toast, Inc. misses on earnings expectations. Reported EPS is $0.05 EPS, ...
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled ...
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)1 and OXB,1 today announce the start of LENTICLAIRTM 1, a Phase I/II trial ...